Scholars Central

OpinionPublished 24 Aug 2022

Nucleic acid aptamers and its applications in microbial infections.

Authors: Jonghoe Heonyong

Archives of Industrial Biotechnology

Volume 6 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Due to the rising prevalence of germs that are resistant to a wide range of drugs, the complexity of treatment and rising healthcare expenditures, treating bacterial infections is a significant challenge today. Furthermore, there aren't many novel antibacterial therapies. Monoclonal antibodies are being replaced by oligonucleotide aptamers, which are single-stranded DNAs or RNAs having a target-selective high-affinity property. The use of aptamer-based systems in drug delivery systems and the reduction or inhibition of the effects of bacterial toxins have been proven to be effective methods for treating microbial illnesses. They also exhibit promising antibiofilm and antibacterial capabilities. The therapeutic uses of aptamers in infections are the main subject of this review.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Archives of Industrial Biotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Industrial Biotechnology
  • SubjectBiochemistry & Biotechnology
  • SubjectEngineering
  • BylineArticles whose byline prints “Jonghoe Heonyong”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels